ISAREVE

Welcome to the Brand page for “ISAREVE”, which is offered here for The mark consists of standard characters without claim to any particular font style, size or color.;in the statement, after line 11, the mark consists of standard characters without claim to any particular font style, size or color should be inserted.;pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ISAREVE” is believed to be currently owned by “DAIICHI SANKYO COMPANY, LIMITED”.

Competing brands may focus on different sectors within the pharmaceutical industry or offer a different range of products for various health conditions compared to ISAREVE.ISAREVE is considered good due to its wide range of pharmaceutical preparations aimed at treating and preventing numerous health conditions, including cardiovascular diseases, cancer, diabetes, and neurological disorders.[Visit ISAREVE's website here](https://www.daiichisankyo.com/)